| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.03▼ | 1.03▼ | 1.03▼ | 1.08▼ | 1.23▼ |
| MA10 | 1.03▼ | 1.05▼ | 1.05▼ | 1.12▼ | 1.68▼ |
| MA20 | 1.08▼ | 1.11▼ | 1.11▼ | 1.17▼ | 2.66▼ |
| MA50 | 1.15▼ | 1.20▼ | 1.27▼ | 1.77▼ | 4.96▼ |
| MA100 | 1.44▼ | 1.53▼ | 1.62▼ | 2.82▼ | 27.49▼ |
| MA200 | 1.73▼ | 2.13▼ | 2.16▼ | 3.95▼ | 173.97▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.001▼ | 0.002▲ | 0.028▲ | 0.121▲ |
| RSI | 34.769▼ | 35.203▼ | 35.410▼ | 30.136▼ | 37.500▼ |
| STOCH | 13.389▼ | 6.155▼ | 3.156▼ | 11.295▼ | 2.350▼ |
| WILL %R | -90.909▼ | -93.750▼ | -95.652▼ | -96.295▼ | -99.690▼ |
| CCI | -89.978 | -76.446 | -79.078 | -195.261▼ | -100.585▼ |
|
Friday, November 06, 2026 01:15 AM
HCW11-018b induces/promotes tertiary lymphoid structure formation inside tumorsHCW11-018b converts immunological “cold” tumors into “hot” ...
|
|
Thursday, November 05, 2026 05:45 AM
Provides funding needed to complete HCW9302 Phase 1 study in alopecia areata and establish Recommended Phase 2 DoseMIRAMAR, Fla., Nov. 05, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or ...
|
|
Thursday, September 24, 2026 09:36 AM
HCW Biologics has agreed to sell 903,614 units at $1.6599 each, raising approximately $1.5 million in gross proceeds via pre-funded warrants and potential common warrants. The funds will be used for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 1.0248 | 1.045 | 1.01 | 1.02 | 22,433 |
| 05/11/26 | 1.11 | 1.11 | 1.01 | 1.04 | 88,075 |
| 04/11/26 | 1.10 | 1.15 | 1.08 | 1.08 | 17,600 |
| 03/11/26 | 1.18 | 1.18 | 1.09 | 1.15 | 37,764 |
| 02/11/26 | 1.1104 | 1.2799 | 1.10 | 1.12 | 73,644 |
| 30/10/26 | 1.16 | 1.1894 | 1.10 | 1.10 | 33,172 |
| 29/10/26 | 1.18 | 1.22 | 1.16 | 1.18 | 33,336 |
| 28/10/26 | 1.16 | 1.24 | 1.16 | 1.22 | 53,357 |
| 27/10/26 | 1.12 | 1.15 | 1.10 | 1.14 | 19,915 |
| 26/10/26 | 1.17 | 1.18 | 1.10 | 1.10 | 30,444 |
|
|
||||
|
|
||||
|
|